Aragona Caterina Oriana, Bagnato Gianluca, Tomeo Simona, Rosa Daniela La, Chiappalone Marianna, Tringali Maria Concetta, Singh Emanuele Balwinder, Versace Antonio Giovanni
Department of Emergency, Unit of Emergency Mecicine, AOU Policlinico "G.Martino", University of Messina, Messina, Italy.
J Cardiovasc Echogr. 2023 Jan-Mar;33(1):10-16. doi: 10.4103/jcecho.jcecho_11_23. Epub 2023 May 29.
Coronavirus disease 2019 (COVID-19) is characterized by multi-organ involvement, including respiratory and cardiac events. Echocardiography is widely considered the first-choice tool for the evaluation of cardiac structures and function because of its reproducibility, feasibility, easy to use at bedside, and for good cost-effectiveness. The aim of our literature review is to define the utility of echocardiography in the prediction of prognosis and mortality in COVID-19 patients with mild to critical respiratory illness, with or without known cardiovascular disease. Moreover, we focused our attention on classical echocardiographic parameters and the use of speckle tracking to predict the evolution of respiratory involvement. Finally, we tried to explore the possible relationship between pulmonary disease and cardiac manifestations.
2019冠状病毒病(COVID-19)的特征是多器官受累,包括呼吸和心脏方面的症状。由于超声心动图具有可重复性、可行性、便于床旁操作以及良好的成本效益,因此被广泛认为是评估心脏结构和功能的首选工具。我们进行文献综述的目的是确定超声心动图在预测患有轻至重症呼吸道疾病、有无已知心血管疾病的COVID-19患者的预后和死亡率方面的效用。此外,我们重点关注经典超声心动图参数以及使用斑点追踪技术来预测呼吸受累的进展情况。最后,我们试图探究肺部疾病与心脏表现之间可能存在的关系。